Sopharma Trading Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
3,696
- Stock Symbol
-
SFT
- Investments
-
7
- Share Price
-
$3.70
- (As of Tuesday Closing)
Sopharma Trading General Information
Description
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
Contact Information
Website
www.sopharmatrading.comCorporate Office
- 5 Lachezar Stanchev Street
- Sopharma Business Towers, Building A, Floor 12
- Sofia, 1756
- Bulgaria
Corporate Office
- 5 Lachezar Stanchev Street
- Sopharma Business Towers, Building A, Floor 12
- Sofia, 1756
- Bulgaria
Sopharma Trading Stock Performance
As of 17-Nov-2026, Sopharma Trading’s stock price is $3.70. Its current market cap is $127M with 34.3M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.70 | $3.70 | $3.21 - $6.82 | $127M | 34.3M | 5.48K | $0.88 |
Sopharma Trading Financials Summary
As of 31-Mar-2026, Sopharma Trading has a trailing 12-month revenue of $1.37B.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 330,934 | 362,388 | 344,238 | |
| Revenue | 1,365,411 | 1,309,774 | 1,070,127 | 921,942 |
| EBITDA | 69,908 | 72,192 | 50,981 | 40,902 |
| Net Income | 29,899 | 33,354 | 22,192 | 16,092 |
| Total Assets | 554,534 | 561,097 | 425,430 | 361,703 |
| Total Debt | 201,337 | 208,586 | 147,042 | 141,622 |
Sopharma Trading Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sopharma Trading Signals
Sopharma Trading Investments & Acquisitions (7)
Sopharma Trading’s most recent deal was a Merger/Acquisition with Great Pharmacy. The deal was made on 10-Oct-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Great Pharmacy | 10-Oct-2024 | Merger/Acquisition | Distributors (Healthcare) | ||
| Royal Pharmacy (Nine Pharmacies in Sofia, Bulgaria) | 07-Dec-2023 | Corporate Asset Purchase | Specialty Retail | ||
| SCS Franchise | 01-Oct-2020 | Merger/Acquisition | Other Healthcare Services | ||
| Sanita Franchising | 01-Oct-2020 | Merger/Acquisition | Specialty Retail | ||
| Sopharmacy | 14-Sep-2017 | Merger/Acquisition | Specialty Retail |
Sopharma Trading ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Distribution
Subindustry
Rank
Percentile
Sopharma Trading FAQs
-
When was Sopharma Trading founded?
Sopharma Trading was founded in 2006.
-
Where is Sopharma Trading headquartered?
Sopharma Trading is headquartered in Sofia, Bulgaria.
-
What is the size of Sopharma Trading?
Sopharma Trading has 3,696 total employees.
-
What industry is Sopharma Trading in?
Sopharma Trading’s primary industry is Distributors (Healthcare).
-
Is Sopharma Trading a private or public company?
Sopharma Trading is a Public company.
-
What is Sopharma Trading’s stock symbol?
The ticker symbol for Sopharma Trading is SFT.
-
What is the current stock price of Sopharma Trading?
As of 17-Nov-2026 the stock price of Sopharma Trading is $3.70.
-
What is the current market cap of Sopharma Trading?
The current market capitalization of Sopharma Trading is $127M.
-
What is Sopharma Trading’s current revenue?
The trailing twelve month revenue for Sopharma Trading is $1.37B.
-
What is Sopharma Trading’s annual earnings per share (EPS)?
Sopharma Trading’s EPS for 12 months was $0.88.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process